Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11969434 Oral allopregnanolone compositions and methods of use
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
August 29, 2022
0
Date of Patent
April 30, 2024
0
Patent Applicant
Lipocine
0
Patent Application Number
17823080
0
Patent Citations
US Patent 8975245 Anaesthetic formulation
0
US Patent 9358298 17-hydroxyprogesterone ester containing oral compositions and related methods
0
US Patent 9358299 17-hydroxyprogesterone ester-containing oral compositions and related methods
0
US Patent 9364547 17-hydroxyprogesterone ester containing oral compositions and related methods
0
US Patent 9375437 Progesterone containing oral dosage forms and kits
0
US Patent 9399069 17-Hydroxyprogesterone ester containing oral compositions and related methods
0
US Patent 9757391 Neuroactive steroids and their use to facilitate neuroprotection
0
US Patent 10022384 17-hydroxyprogesterone ester-containing oral compositions and related methods
0
US Patent 10251894 Anticonvulsant activity of steroids
0
US Patent 10322139 Neuroactive steroid formulations and methods of treating CNS disorders
0
•••
Patent Inventor Names
Kongnara Papangkorn
0
Samuel Akapo
0
Joel Frank
0
Nachiappan Chidambaram
0
Jonathan Ogle
0
Benjamin J. Bruno
0
Mahesh V. Patel
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
11969434
0
Patent Primary Examiner
San Ming R Hui
0
CPC Code
A61K 31/557
0
A61K 9/0053
0
A61K 31/57
0
Find more entities like US Patent 11969434 Oral allopregnanolone compositions and methods of use
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE